Exicure XCUR
NASDAQ XCUR
$1.15 -0.15 (-11.54%)
As of: Aug 21, 2026 · 3:59 PM EDT

Exicure (XCUR) Cash from Investing Activities (2016 - 2025)

Exicure's (XCUR) quarterly Cash from Investing Activities came in at $455000.0 in Q4 2025, up 321.3% on a QoQ basis from $108000.0 in Q3 2025.

Exicure (XCUR) Cash from Investing Activities (2016 - 2025) Analysis & Trends

Exicure (XCUR) has 9 years of Cash from Investing Activities data on file, last reported at $455000.0 in Q4 2025.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to $455000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $283000.0 (up 113.54% YoY) and the FY2025 annual result came in at -$1.8 million, changed N/A from the prior year.
  • Cash from Investing Activities grew to $455000.0 in Q4 2025, from $108000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $19.2 million in Q2 2021 to a low of -$2.1 million in Q1 2025.
  • A 4-year average of $3.0 million and a median of $711000.0 in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities jumped 443.7% — and 2023, when it slumped 226.67%.
  • Tracing XCUR's Cash from Investing Activities over 4 years: stood at $4.1 million in 2021, then sank by 94.96% to $207000.0 in 2022, then jumped by 243.48% to $711000.0 in 2023, then sank by 36.01% to $455000.0 in 2025.
  • The last three Cash from Investing Activities figures came in at $455000.0 (Q4 2025), $108000.0 (Q3 2025), and -$280000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Exicure 7.27 Mn 7.27 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 455,000.00
Dec 31, 2025 455,000.00
Sep 30, 2025 108,000.00
Sep 30, 2025 108,000.00
Jun 30, 2025 -280,000.00
Jun 30, 2025 -280,000.00
Mar 31, 2025 -2.09 Mn
Mar 31, 2025 -2.09 Mn
Dec 31, 2023 711,000.00
Dec 31, 2023 711,000.00
Jun 30, 2023 -1.90 Mn
Jun 30, 2023 -1.90 Mn
Mar 31, 2023 106,000.00
Mar 31, 2023 106,000.00
Dec 31, 2022 207,000.00
Dec 31, 2022 207,000.00
Sep 30, 2022 998,000.00
Sep 30, 2022 998,000.00
Jun 30, 2022 1.50 Mn
Jun 30, 2022 1.50 Mn